J&K administration issues fresh COVID-19 guidelines for devotees visiting Mata Vaishno Devi; check details here

-

To prevent and control the COVID-19 spread, the Jammu and Kashmir administration has issued fresh guidelines for pilgrims visiting the famous Mata Vaishno Devi shrine. The state executive committee took up this decision during a review meeting regarding the current situation in the union territory.

Post the meeting, the committee announced that pilgrims must carry a valid and verifiable RT-PCR or Rapid Antigen Test along with them while visiting the shrine. Also, the test should not be older than 72 hours.

“Valid and verifiable RT-PCR/Rapid Antigen Test not older than 72 hours of arrival should be made mandatory. Only those pilgrims will be allowed to visit the shrine who do not show any COVID-19 related symptoms," the order stated. Further in the order, it is mentioned that there will be strict adherence to COVID-19 appropriate behaviour or SOPs which must be followed at all times.

Reports also suggest that these revised guidelines have been issued after observing an uneven trend in the coronavirus cases in Jammu and Kashmir. As per recent updates, a total of 108 fresh cases were recorded yesterday, with 21 new cases in Jammu and 87 fresh cases in Kashmir.

With this, the tally has risen to 3,31, 494 while the death toll remains unchanged at 4,429 overall.

Check fresh guidelines here:

-Tourists should show a valid and verifiable RT-PCR/Rapid Antigen Test which is not older than 72 hours of arrival

-As per COVID-19 SOPs, the premises of the shrine must be properly sanitised

- Along with Standard Operating Procedure (SOPs), strict adherence to COVID-19 appropriate behaviour must be followed by all

- Those tourists who do not show any COVID-19 related symptoms will be allowed to visit the shrine

People visiting the shrine should note that there is no specific time in a year to visit Vaishno Devi. There is also an app where devotees can access the live darshan.

 



from Firstpost India Latest News https://ift.tt/3m76PBl
FP Trending

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more